|
2024
|
Invention
|
Pharmaceutical composition for oral administration of edaravone and method of administering same.... |
|
|
Invention
|
Drug conjugates of cmet monoclonal binding agents, and uses thereof.
Presented herein are novel ... |
|
|
Invention
|
Information processing device, information processing system, information processing method, prog... |
|
|
Invention
|
Sulfonamide or sulfinamide compound having effect of inducing brd4 protein degradation and pharma... |
|
|
Invention
|
Oral composition containing inorganic porous body. 2232233. |
|
|
Invention
|
Salt-inducible kinase inhibitory compound and pharmaceutical composition containing same. The pre... |
|
|
Invention
|
Method for predicting efficacy of bispecific fusion polypeptide in subject. Provided is a method ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of Parkinson’s disease. |
|
|
Invention
|
Novel b0at1 inhibitor. The purpose of the present invention is to provide a novel B0AT1 inhibitor... |
|
|
Invention
|
Pharmaceutical composition for treatment of multisystem atrophy or inhibiting progress of multisy... |
|
|
Invention
|
Composition and method for treating or preventing tar dna-binding protein 43 related disease. A c... |
|
|
Invention
|
Edaravone suspension for oral administration.
An edaravone suspension for human oral administrat... |
|
|
Invention
|
Compounds and their use.
The specification generally relates to compounds of Formula (I), and ph... |
|
|
Invention
|
Novel 3, 5-disubstituted pyridine and 3, 5-disubstituted pyridazine derivatives and pharmaceutica... |
|
|
Invention
|
Cereblon e3 ligase binding compound, pharmaceutical composition containing same, and production m... |
|
2023
|
Invention
|
Crystalline forms of nlrp3 inflammasome inhibitors, chemical processes and chemical compounds. Th... |
|
|
Invention
|
Nlrp3 inflammasome inhibitors. The specification generally relates to compounds of Formula (I), F... |
|
|
Invention
|
Method for producing production intermediate, production intermediate thereof, and method for pro... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of parkinsons disease |
|
|
G/S
|
Rental of smartphones; Rental of smartphones featuring embedded software for detecting symptoms o... |
|
|
Invention
|
Agent for preventing or treating disease associated with accumulation of abnormal protein aggrega... |
|
|
Invention
|
Method for treating amyotrophic lateral sclerosis and method for suppressing progress of amyotrop... |
|
|
Invention
|
Anti-adiponectin receptor antibody and utilization of same. Provided is an anti-adiponectin antib... |
|
|
Invention
|
Optically active pyrrolidine compound and method for producing same.
The present invention provi... |
|
|
Invention
|
Agent for eliminating senescent cells.
The present invention provides an agent or pharmaceutical... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of Parkinson's disease. |
|
|
Invention
|
Orally disintegrating tablet. The present invention relates to an orally disintegrating tablet. A... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of Parkinson's disease |
|
|
G/S
|
Pharmaceutical preparations for the treatment of parkinson's disease |
|
|
Invention
|
Pharmaceutical composition containing 1-{2-[(3s,4r)-1-{[(3r,4r)-1-cyclopentyl-3-fluoro-4-(4-metho... |
|
|
Invention
|
Analysis method of 3-methyl-1-phenyl-2-pyrazolin-5-one active pharmaceutical ingredient, treatmen... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of Parkinson's disease |
|
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Injectable pharmaceuticals. |
|
|
G/S
|
Medicinal preparations in the form of capsules. |
|
|
Invention
|
Composition and method for evaluating responsiveness of edaravone. The composition according to t... |
|
|
Invention
|
Human anti-il-33 neutralizing monoclonal antibody.
An antibody has an antagonistic effect agains... |
|
|
Invention
|
Solid forms of rxfp1 modulators. The specification generally relates to solid forms, for example,... |
|
|
Invention
|
Information processing system, information processing method, program, and recording medium. [Pro... |
|
|
Invention
|
Information processing system, information processing method, and program. [Problem] To provide a... |
|
|
Invention
|
Information processing device, information processing system, information processing method and p... |
|
|
Invention
|
Medical agent for treating or suppressing progression of amyotrophic lateral sclerosis. Disclosed... |
|
|
Invention
|
Novel use of melanocortin-1 receptor agonist. A medicine for treating or preventing interstitial ... |
|
2022
|
Invention
|
Information processing system, information processing method, and program.
[Problem] For easily ... |
|
|
Invention
|
Soluble pharmaceutical compositions comprising salts of disubstituted 1, 2, 4-triazine compound. ... |
|
|
G/S
|
Providing medical information about Erythropoietic Protoporphyria (EPP) and X-Linked Protoporphyr... |
|
|
Invention
|
Information processing device, information processing system, information processing method, and ... |
|
|
Invention
|
Novel anti-pad4 antibody.
Provided is an anti-PAD4 antibody or an antibody fragment thereof, whe... |
|
2021
|
G/S
|
Pharmaceutical preparations for the treatment of central nervous system diseases, namely amyotrop... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical ... |
|
|
G/S
|
Pharmaceutical preparations; medicines for human purposes. |
|
|
Invention
|
Neuromuscular disease evaluation system.
A neuromuscular disease evaluation device that is less ... |
|
|
Invention
|
Triazine compound salt, crystal form thereof, and production method therefor.
The present invent... |
|
|
G/S
|
Pharmaceutical preparations for treatment of porphyrin metabolism disorders; pharmaceutical prepa... |
|
|
G/S
|
Pharmaceutical preparations for treatment of porphyrin
metabolism disorders; pharmaceutical prep... |
|
|
Invention
|
Agent for preventing or treating muscular disease.
A myoregulin inhibitor such as an antisense o... |
|
|
Invention
|
Modulation of drug-drug interactions of vadadustat.
Provided herein are methods for reducing, mi... |
|
|
Invention
|
Prophylactic or therapeutic agent for porphyria.
A medicament for treatment or prevention of por... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of Parkinson's disease. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of Parkinson's
disease. |
|
|
G/S
|
Pharmaceutical preparations; medicines for human purposes;
pharmaceutical preparations for the t... |
|
|
Invention
|
Hydroxypyrrolidine derivative and medicinal application thereof.
The present invention provides ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of parkinson's disease. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of parkinson's
disease. |
|
2020
|
Invention
|
Agent for preventing or treating acute-phase neuromyelitis optica.
This invention provides an ag... |
|
|
Invention
|
Therapeutic methods using vadadustat.
This invention provides methods for the treatment of anemi... |
